-
-
-
-
-
-
-
Heron Therapeutics Appoints Stephen Davis to Board of Directors
-
-
-
-
-
-
-
Pacira Pharma (PCRX) Shares Could Stablize But Not Rebound - Mizuho
-
-
-
-
-
-
-
Heron Therapeutics (HRTX) Announces Conclusion of FDA Review of SUSTOL NDA; Provides Update
-
-
-
-
-
-
-
Pre-Open Stock Movers 01/15: (HMY) (DGLY) (WYNN) Higher; (SRPT) (HRTX) (TASR) Lower (more...)
-
-
-
-
-
-
-
Heron Therapeutics Announces Oral Presentation of Data from Completed Phase 3 MAGIC Study for SUSTOLĀ® at the ASCO Breast Cancer Symposium
-
-
-
-
-
-
-
Pre-Open Stock Movers 06/16: (AERI) (ACUR) (COTY) Higher; (AAVL) (CPST) (TWTR) Lower (more...)
-
-
-
-
-
-
-
Heron Therapeutics Announces Positive Outcome from Meeting with FDA for HTX-019
-
924,100 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All